LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Open Letter to Member States on the EU Court Ruling on Mutagenesis

09/05/2019
POSITION PAPER

Open Letter to Member States on the EU Court Ruling on Mutagenesis

09 May 2019

Dear Madam, dear Sir,

We, the undersigned European organisations, are writing to reiterate our concern about the European Court of Justice ruling on case C-528/16 (25 July 2018), by which the Court interpreted the provisions of the EU GMO Directive 2001/18 in such a way that products resulting from innovative, targeted mutagenesis methods are regulated under the provisions of the GMO-Directive.

The introduction of targeted genetic variation in crops and other organisms can help to achieve important sustainable development goals and to contribute to a cleaner environment, to healthy diets, and the protection of biodiversity. It can also contribute to making crops more resilient and better withstand climate change.

The costly and lengthy EU approval process for the products resulting from targeted mutagenesis, combined with potential national cultivation opt-outs under Directive 2001/18, will effectively deprive European farmers & consumers from the benefits of these products. Furthermore, the ruling is hindering the delivery to the market of innovative bio-based products and sustainable industrial, agricultural and healthcare solutions that involve gene-edited microorganisms. Some of the EUs most innovative sectors will effectively be cut off from scientific progress and be put at a competitive disadvantage compared to a rapidly growing group of countries with more enabling regulations.

The ruling is also difficult to implement and virtually impossible to enforce, given that many gene-edited products may be indistinguishable from products changed by natural processes or with conventional breeding techniques, as reconfirmed by the report of the Joint research Centre “Detection of food and feed plant products obtained by new mutagenesis techniques”, published on 26 March 2019.

The report highlights two aspects that are of major importance:
1) “For non-unique DNA alterations affecting one or a few DNA base pairs, an applicant may not be able to develop an event-specific method.”
2) “Plant products obtained by genome editing may enter the market undetected. Moreover, if a suspicious product with an unknown or non-unique DNA alteration would be detected on the EU market, it would be difficult or even impossible to provide court-proof evidence that the modified sequence originated from genome editing.“

We are in full agreement with scientists, stakeholders and EU trade partners, that it has become urgent for the EU to adapt its legislation to reflect and welcome technical progress and align it with legislation in other parts of the world. We are committed to engaging with policy makers, stakeholders and all interested parties to work for a constructive, targeted change. Our goal is to obtain practical and science-based rules for products resulting from the latest mutagenesis methods that foster public confidence and trust. This would unlock great potential for a high-performing, innovative and diversified European bio-based solutions in sectors such as plant and animal breeding, agriculture, animal feed, food, healthcare and energy thereby contributing to Europe’s resilience to climate change, and to benefits for consumers, patients and the environment.

Products should not be subject to Directive 2001/18 requirements and related regulations if they could also have been obtained through conventional methods or result from spontaneous processes in nature. We wish to emphasize that this position is also increasingly adopted as a principal regulatory approach in a growing number of countries around the world. It should also create legal certainty for EU operators by avoiding that Member States adopt individual national rules for products resulting from conventional, random mutagenesis. It will furthermore prevent that two otherwise indistinguishable products or organisms are regulated in two different ways, which would open the door to unfair competition with imports from non-EU countries.

We therefore call upon member states and the EU Commission to initiate a legislative change that provides innovation-friendly rules.

Yours sincerely,

Céline Duroc, Director General | MAIZ'EUROP' for the Platform Agriculture and Progress
Patrick Fox, Secretary General | Association of Manufacturers and Formulators of Enzyme Products
Dirk Carrez, Executive Director | Bio-based Industries Consortium
Marc Vermeulen, Executive Director Specialty Chemicals | The European Chemical Industry Council
Marie-Christine Ribera, Director General | European Association of Sugar Manufacturers
Jérôme Bandry, Secretary General | CEMA - European Agricultural Machinery
Elisabeth Lacoste, Director | C.I.B.E. International Confederation of European Beet Growers
Iliana Axiotiades, Secretary General | European Association of Cereals, Rice, Feedstuffs, Oil Seeds, Olive Oil, Oils and Fats and Agrosupply Trade
Marc Casier, President | Confederation of European Yeast Producers
Ana Granados Chapatte, Director | European Forum of Farm Animal Breeders
Jean-Philippe Azoulay, Director General | European Crop Protection Association
Bernard Valluis, President | European Flour Milling Association
Patrick FOX, Secretary General | EFFCA - European Food and Feed Cultures Association
Thierry de l'ESCAILLE, Secretary General - CEO | European Landowners' Organization
Raquel Izquierdo, Secretary General | European Potato Trade Association
Susanne Meyer, Secretary General | EUVEPRO - European Vegetable Protein Association
Garlich von Essen, Secretary General | ESA - European Seed Association
Joanna Dupont-Inglis, Secretary General |EuropaBio – The European Association for Bioindustries
Aleksandra Malyska, Executive Manager | European Technology Platform Plants for the Future
Nick Major, President | European Feed Manufacturers' Federation
Joerg Seifert, Secretary General | FEFANA - EU Association of Specialty Feed Ingredients and their Mixtures
Ernesto Morgado, President | Federation of European Rice Millers
Nathalie Lecocq, Director General | FEDIOL - EU Vegetable Oil and Protein Meal Industry Association
Mella Frewen, Director General |FoodDrinkEurope
Jamie Fortescue, Managing Director | Starch Europe
Sylvie Mamias, Secretary General | UNION FLEURS


Download the file below to read the full letter.

Open Letter to Member States on the EU Court Ruling on Mutagenesis


Download
2019_05_G_PP_ESA_19.0299-Letter-to-Member-States-at-ScopaffsDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.